BioSpace News Archive

Genetown

Oncorus to Present at the Jefferies Global Healthcare Conference - June 01, 2022

Oncorus, Inc. announced that President and Chief Executive Officer, Theodore Ashburn, M.D., Ph.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 8, 2022 at 3:30 p.m. ET in New York, NY.

June 1, 2022
·
1 min read
Pharm Country

Zynerba Pharmaceuticals Presents Data on Zygel™ at the American Society of Clinical Psychopharmacology Annual Meeting

Zynerba Pharmaceuticals, Inc. is presenting an oral podium presentation and a poster presentation at the American Society of Clinical Psychopharmacology Annual Meeting, being held May 31 – June 3, 2022, in Scottsdale, Ariz.

June 1, 2022
·
7 min read
Drug Development

Societal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101

Societal CDMO, Inc. announced that it has been selected by AmyriAD Pharma to provide CDMO services to support the ongoing clinical development of AD101.

June 1, 2022
·
4 min read
Pharm Country

Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,345,896 to the Company on May 31, 2022.

June 1, 2022
·
10 min read
Policy

Apellis Announces Submission of New Drug Application to the FDA for Pegcetacoplan for Geographic Atrophy

Apellis Pharmaceuticals, Inc. announced that the company has submitted a New Drug Application to the United States Food and Drug Administration for intravitreal pegcetacoplan, an investigational, targeted C3 therapy, for the treatment of geographic atrophy secondary to age-related macular degeneration.

June 1, 2022
·
6 min read
Biotech Bay

IGM Biosciences to Present at the 2022 Jefferies Healthcare Conference

IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the 2022 Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 3:00 p.m. EST in New York.

June 1, 2022
·
1 min read
Pharm Country

Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology 2022 Annual Meeting

Axsome Therapeutics, Inc. announced positive results from the long-term, open-label EVOLVE trial of AXS-05 in major depressive disorder.

June 1, 2022
·
9 min read
Compugen to Present at Upcoming Investor Conferences - June 01, 2022

Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced that management will present at the following investor conferences.

June 1, 2022
·
2 min read
Business

CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries

CytoSorbents Corporation today announced that following a successful pilot program in three countries, the Company has signed an expanded non-exclusive agreement with Nikkiso Europe GmbH (Nikkiso) to distribute their PureADJUST stand-alone hemoperfusion pump and accessories in a total of 14 countries.

June 1, 2022
·
9 min read
Business

SciNeuro Pharmaceuticals Announces a License and Option Agreement with GSK to Progress Development of Novel Therapies for CNS Diseases

SciNeuro Pharmaceuticals (SciNeuro), a leader in the discovery and development of innovative therapeutics for the treatment of CNS diseases, today announced the execution of an exclusive, worldwide license and option agreement with GlaxoSmithKline (GSK).

June 1, 2022
·
2 min read